STOCKHOLDERS' EQUITY - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
STOCKHOLDERS' EQUITY
Weighted average grant date fair values of options granted	$ 19.80	$ 14.59
Options exercised to purchase common stock	133,805	7,927
Proceeds from exercise of employee stock options	$ 86,390	$ 38,035
Intrinsic value of options exercised	3,394,400
Stock option expense	7,057,401	$ 3,993,424
Compensation cost related to nonvested awards not yet recognized	$ 20,229,215
Compensation cost related to nonvested awards not yet recognized, expected weighted-average period for recognition	2 years 8 months 26 days
Common stock
STOCKHOLDERS' EQUITY
Options exercised to purchase common stock	135,776	7,927